Jafron Biomedical Co Ltd operates within the Surgical and medical instruments sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Jafron Biomedical Co Ltd with three other
companies in this sector in CHINA :
Guangzhou Well Lead Medical Equipment Co Ltd
sales of 993.81 million Chinese Renmimbi [US$142.56 million]
of which 99%
was Medical Equipment),
Shanghai Kindly Enterprise Development Group Co Ltd
(1.82 billion Chinese Renmimbi [US$260.64 million]
of which 100%
was Medical device manufacturing), and
Shanghai Kinetic Medical Co Ltd
(1.22 billion Chinese Renmimbi [US$175.34 million]
of which 70%
was Medical Instrument Manufacturing).
During the year ended December of 2019, sales at
Jafron Biomedical Co Ltd were 1.43 billion Chinese Renmimbi (US$205.39 million).
increase of 40.9%
versus 2018, when the company's sales were 1.02 billion Chinese Renmimbi.
This was the fifth consecutive year of sales increases at Jafron Biomedical Co Ltd
(and since 2014, sales have increased a total of 286%).
Sales of Medical Device Manufacturing saw an increase
41.0% in 2019, from
1.01 billion Chinese Renmimbi to 1.43 billion Chinese Renmimbi.
Not all segments of Jafron Biomedical Co Ltd experienced an increase in sales in 2019:
sales of Others fell 11.8% to 2.61 million Chinese Renmimbi.
(However, this segment's sales were only a very small portion of the company's overall sales).